Navigation Links
Sepsis Treatment Offers Lifesaving Potential
Date:6/16/2009

Blood-cleansing therapy used in Japan warrants further study: researchers

TUESDAY, June 16 (HealthDay News) -- A device designed to filter bacteria-produced toxins from the blood of patients with severe sepsis or septic shock appears to improve blood circulation and organ function and lower the risk of death, a preliminary study suggests.

Italian researchers tested whether using a polymyxin B fiber column -- an antibiotic-based hemoperfusion device -- with conventional therapy would improve patient outcomes. Polymyxin B is an antibiotic, and hemoperfusion is blood filtering to remove toxins.

The study included 64 patients with severe sepsis or septic shock who had emergency surgery for intra-abdominal infection. The patients were randomly selected to receive either conventional therapy or conventional therapy plus two sessions of polymyxin B hemoperfusion.

After 28 days, the death rate was 32 percent in the polymyxin B hemoperfusion group and 53 percent in the group that received conventional therapy alone.

The study appears in the June 17 issue of the Journal of the American Medical Association.

"Larger multicenter studies are indicated to confirm these encouraging findings in other patient populations," the Italian researchers wrote.

The therapy used in this study is common in Japan, but not in the United States, according to an accompanying editorial written by Dr. John A. Kellum, of the University of Pittsburgh Medical Center, and Dr. Shigehiko Uchino, of the Jikei University School of Medicine in Tokyo.

Even though preliminary, the findings "suggest a number of interesting hypotheses and should provoke further study. This is essential given the significant ongoing problem that sepsis represents," they wrote.

More information

The MedlinePlus Medical Encyclopedia has more about sepsis.



-- Robert Preidt



SOURCE: Journal of the American Medical Association, news release, June 16, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Scientists Probe Sepsis Deadly Secrets
2. Blacks More Likely to Die of Severe Sepsis
3. Research May Yield New Weapons Against Sepsis
4. Customized treatments for sepsis lower treatment time and reduce length of ICU stays
5. Ashwell receptor reduces mortality during sepsis
6. Educational Drive Cut Death Rate From Sepsis
7. Medical Simulation Corporation Introduces Sepsis Quality Initiative Program
8. Sepsis Therapy in Preemies Fails to Boost Survival
9. Children's National Research Links Platelets to Sepsis-Related Organ Failure
10. Vanderbilt researchers pioneer an advanced sepsis detection and management system
11. New treatment effective in counteracting cocaine-induced symptoms
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Sepsis Treatment Offers Lifesaving Potential 
(Date:10/13/2017)... ... October 13, 2017 , ... ... certification process to promote standards of excellence for the field of eating disorders, ... March 22 – 25, 2018 in Orlando, Florida at the Omni Resort at ...
(Date:10/13/2017)... , ... October 13, 2017 , ... Many families have ... many long-term care insurance companies have a waiver for care if the client has ... period, when the family pays for care, is often waived, so the benefits from ...
(Date:10/13/2017)... ... October 13, 2017 , ... Talented ... the lowdown on sciatica in a new episode of "Success Files," which is ... events and innovation and investigates each subject in-depth with passion and integrity. , ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... are now treating sleep apnea using cutting-edge Oventus O2Vent technology. As ... serious sleep disorder characterized by frequent cessation in breathing. Oral appliances can offer ...
(Date:10/12/2017)... ... October 12, 2017 , ... Asante, a ... health care, have expanded their existing home health joint venture through an agreement, ... been operating a joint venture home health company with Asante, delivering clinically integrated ...
Breaking Medicine News(10 mins):
(Date:9/23/2017)... 2017 Janssen Biotech, Inc. (Janssen) announced today ... the U.S. Food and Drug Administration (FDA) for the ... the treatment of moderately to severely active rheumatoid arthritis ... are needed to further evaluate the safety of sirukumab ... "We are ...
(Date:9/19/2017)... --  ZirMed Inc ., a recognized leader in cloud-based revenue ... been ranked #1 by its users for the seventh consecutive ... Survey. ZirMed was recognized as the top-ranked end-to-end revenue cycle ... over 200 beds and holds one of the longest #1 ... ...
(Date:9/12/2017)... and NEW YORK , Sept. 12, 2017   ... for global supply chains, has published the first annual edition of its ... of more than 20,400 companies evaluated by EcoVadis, based on Scorecard Ratings ... 2016. ... CSR Risk & Performance Index ...
Breaking Medicine Technology: